VINC - Vincerx Pharma - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VINC is currently covered by 2 analysts with an average price target of $3.46. This is a potential upside of $3.45 (34500%) from yesterday's end of day stock price of $0.01.

Vincerx Pharma's activity chart (see below) currently has 12 price targets and 13 ratings on display. The stock rating distribution of VINC is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 47.62% with an average time for these price targets to be met of 295.71 days.

Highest price target for VINC is $117, Lowest price target is $8.

Most recent stock forecast was given by JONATHAN CHANG from LEERINK on 08-Oct-2024. First documented stock forecast 13-Aug-2021.

Currently out of the existing stock ratings of VINC, 3 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$2

$0.91 (83.49%)

1 years 2 months 9 days ago
(08-Oct-2024)

4/4 (100%)

$-6.16 (-75.49%)

166

Buy

$5

1 years 8 months 16 days ago
(01-Apr-2024)

2/2 (100%)

$-9.3 (-65.03%)

654

Buy

$4

$2.91 (266.97%)

$11

3 years 1 months ago
(17-Nov-2022)

4/4 (100%)

$-12.2 (-75.31%)

612

Buy

$6

$1.22 (25.52%)

$12

3 years 6 months 10 days ago
(07-Jun-2022)

1/3 (33.33%)

$4.03 (204.57%)

638

Buy

$30

3 years 8 months 13 days ago
(04-Apr-2022)

0/2 (0%)

$13.71 (84.35%)

Show more analysts

Please expand the browser size to see the chart

What is VINC (Vincerx Pharma) average time for price targets to be met?

On average it took 295.71 days on average for the stock forecasts to be realized with a an average price target met ratio 47.62

Which analyst has the current highest performing score on VINC (Vincerx Pharma) with a proven track record?

MATTHEW BARCUS

Which analyst has the current lower performing score on VINC (Vincerx Pharma) with a proven track record?

MICHAEL KING

Which analyst has the most public recommendations on VINC (Vincerx Pharma)?

Matthew Barcus has 0 price targets and 0 ratings on VINC

Which analyst is the currently most bullish on VINC (Vincerx Pharma)?

Geulah Livshits with highest potential upside - $29.01

Which analyst is the currently most reserved on VINC (Vincerx Pharma)?

Yale Jen with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?